Quality evaluation of commercially available healthcare applications for prostate cancer management

被引：0
|
作者：
Bouarroudj, Kenza [1 ]
Kitouni, Ilham [2 ]
Lechekhab, Abdelmouhsen [3 ]
Leghelimi, Zinelabidine [3 ]
Kara, Issam
机构：
[1] Abdelhamid Mehri Constantine 2 Univ, MISC Lab, Constantine, Algeria
[2] Abdelhamid Mehri Constantine 2 Univ, LISIA Lab, Constantine, Algeria
[3] Abdelhamid Mehri Constantine 2 Univ, Constantine, Algeria
来源：
MULTIMEDIA TOOLS AND APPLICATIONS | 2023年 / 82卷 / 20期
关键词：
Prostate cancer; Artificial intelligence; MARS; HAs; RADIOTHERAPY;
D O I：
10.1007/s11042-023-15601-9
中图分类号：
TP [自动化技术、计算机技术];
学科分类号：
0812 ;
摘要：
Many prostate cancer health applications are available on the software market. The main software solutions focus on helping patients cope with prostate cancer, helping urologists manage medical records and helping radiologists interpret multi-parametric magnetic resonance imaging. Some of these applications for prostate cancer make use of artificial intelligence. It is believed that artificial intelligence will play a key role in facilitating the clinical practice of health professionals and providing psychological support to patients. This study aims to assess the quality of commercially available applications for prostate cancer management.
引用
收藏
页码：31793 / 31819
页数：27
相关论文
共 50 条
  • [1] Quality evaluation of commercially available healthcare applications for prostate cancer management
    Kenza Bouarroudj
    Ilham Kitouni
    Abdelmouhsen Lechekhab
    Zinelabidine Leghelimi
    Issam Kara
    Multimedia Tools and Applications, 2023, 82 : 31793 - 31819
  • [2] Comparison between two commercially available chromogranin A assays in detecting neuroendocrine differentiation in prostate cancer and benign prostate hyperplasia
    Zitella, Andrea
    Berruti, Alfredo
    Destefanis, Paolo
    Mengozzi, Giulio
    Torta, Mirella
    Ceruti, Carlo
    Casetta, Giovanni
    Mosca, Alessandra
    Greco, Alessandro
    Rolle, Luigi
    Aimo, Giuseppe
    Aroasio, Emiliano
    Tizzani, Alessandro
    Dogliotti, Luigi
    Fontana, Dario
    CLINICA CHIMICA ACTA, 2007, 377 (1-2) : 103 - 107
  • [3] Accuracy of commercially available smartphone applications for the detection of melanoma
    Sun, M. D.
    Kentley, J.
    Mehta, P.
    Dusza, S.
    Halpern, A. C.
    Rotemberg, V.
    BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : 744 - 746
  • [4] Molecular analysis and characterization of PrEC, commercially available prostate epithelial cells
    Sobel, Richard E.
    Wang, Yuzhuo
    Sadar, Marianne D.
    IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL, 2006, 42 (1-2) : 33 - 39
  • [5] Molecular analysis and characterization of PrEc, commercially available prostate epithelial cells
    Richard E. Sobel
    Yuzhuo Wang
    Marianne D. Sadar
    In Vitro Cellular & Developmental Biology - Animal, 2006, 42 : 33 - 39
  • [6] Evaluation of sexual dysfunction in prostate cancer management
    Savareux, L.
    Droupy, S.
    PROGRES EN UROLOGIE, 2009, 19 : S187 - S190
  • [7] Evaluation and Management of Rectourethral Fistula Following Radiation Treatment for Prostate Cancer
    Ramón Virasoro
    Mary H. James
    Kurt A. McCammon
    Current Bladder Dysfunction Reports, 2012, 7 (4) : 275 - 280
  • [8] Evaluation and Management of Rectourethral Fistula Following Radiation Treatment for Prostate Cancer
    Virasoro, Ramon
    James, Mary H.
    McCammon, Kurt A.
    CURRENT BLADDER DYSFUNCTION REPORTS, 2012, 7 (04) : 275 - 280
  • [9] Surveillance after prostate cancer radiotherapy: Evaluation and management of toxicity and relapse
    Dupic, G.
    Hennequin, C.
    CANCER RADIOTHERAPIE, 2015, 19 (6-7): : 582 - 589
  • [10] A Review on Novel Applications of Nanotechnology in the Management of Prostate Cancer
    Khanam, Arshi
    Singh, Gurvirender
    Narwal, Smita
    Chopra, Bhawna
    Dhingra, Ashwani K.
    CURRENT DRUG DELIVERY, 2024, 21 (09) : 1161 - 1179
12345